Medicortex International AB (publ) (NGM:MEDFIN)
Sweden · Delayed Price · Currency is SEK 1.125
-0.075 (-6.25%)
At close: Oct 26, 2026
Medicortex International AB Company Description
Medicortex International AB (publ), through its subsidiary, Medicortex Finland Oyj, develops diagnostic tests based on biomarkers for traumatic brain injury, concussions, and other neurodegenerative conditions.
It develops ProbTBI, a diagnostic test for urine; and IndicateTBI, a diagnostic test for saliva. It operates in Finland and Sweden.
The company was formerly known as Nosium AB (publ) and changed its name to Medicortex International AB (publ) in July 2026.
Medicortex International AB (publ) was founded in 2014 and is based in Stockholm, Sweden.
Medicortex International AB (publ)
| Country | Sweden |
| Founded | 2014 |
| Industry | Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations |
| Employees | 3 |
| CEO | Adrian Harel |
Contact Details
Address: Kivra: 556519-7729 Stockholm, 106 31 Sweden | |
| Phone | 46 7 08 60 60 07 |
| Website | medicortex.eu |
Stock Details
| Ticker Symbol | MEDFIN |
| Exchange | Nordic Growth Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0023112065 |
| SIC Code | 2840 |
Key Executives
| Name | Position |
|---|---|
| Adrian Harel | Chief Executive Officer |
| Jesper Yrwing | Chief Financial Officer |
| Pihla Miettinen | Chief Operating Officer |